Evaluation of the Novel Implant Disease Risk Assessment : a Retrospective Study (IDRA)
NCT ID: NCT04888572
Last Updated: 2022-10-26
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
500 participants
OBSERVATIONAL
2021-05-11
2022-12-20
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Association Between Restorative Emergence Profiles and Peri-implant Bone Loss in Different Implant Systems:
NCT06544746
A Study of the Crestal Bone Loss Around Bone Level Versus Tissue Level Implants in Non-compliant Patients With Healthy or Reduced Periodontium After 5-8 Years in Function
NCT04942808
Immediate Implant Placement in Fresh Extraction Sockets and Delayed Implants in Healed Sockets.
NCT04346706
Patients' Illness Perception of Peri-implant Diseases. A Cross-sectional Study
NCT06383351
Evaluation of the Patient's Risk Profile Using the Peri-implantitis Risk Diagram
NCT05618171
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
As a result, each patient will have a personalized IDRA chart and they will be either at low, medium or high risk of developing peri-implantitis.
The retrospective analysis of the files being completed, the patients will be called to come to the Department of Periodontology in order to take the necessary measures to verify the presence or absence of a possible peri-implantitis on the one hand or the loss of the implant on the other hand.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
RETROSPECTIVE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Peri-Apical X-ray
Using a PCP UNC 15 Hu Friedy® periodontal probe and a gentle horizontal sweeping motion through the peri-implant "tunnel" or sulcus the examiner will assess bleeding on probing, the main factor in determining peri-implant inflammation and subsequently possible peri-implantitis. Then, using the same instrument, the author will examine whether there is an increase in the values of pocket depths compared to the initial values, highlighting an installation of peri-implant disease. Radiographically, evidence of bone loss after healing through taking a digital x-ray that will be viewed on DBSWIN® software will help authors make a diagnosis of peri-implantitis as well. It will be required that the digital film be perfectly parallel to the axis of the implant and the X-ray tube perpendicular to them in order to have an orthogonal radiograph.
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Patients who have placed one or more implants in the last five years at the Departments of Periodontology or Oral Surgery of the FMD and the implants have / have been loaded.
3. Patients whose periodontal file has been completed and the periodontal parameters required for IDRA reported.
4. Patients having an x-ray with the loaded implant or an x-ray during the try-in of the infrastructure.
Exclusion Criteria
2. Patients not having an x-ray after loading the implant or during the try-in of the infrastructure
3. Totally edentulous patients.
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Saint-Joseph University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Tamara Rbeiz
Doctor of Dental Surgery
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Tamara Rebeiz, DentalSurg
Role: PRINCIPAL_INVESTIGATOR
Saint-Joseph University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Saint Joseph University
Beirut, , Lebanon
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Heitz-Mayfield LJA, Heitz F, Lang NP. Implant Disease Risk Assessment IDRA-a tool for preventing peri-implant disease. Clin Oral Implants Res. 2020 Apr;31(4):397-403. doi: 10.1111/clr.13585. Epub 2020 Feb 20.
Rebeiz T, Nasr L, Kassir AR, Menassa G, Chakar C. Assessment of the association between the Implant Disease Risk Assessment (IDRA) tool and peri-implantitis: a retrospective cohort study with up to 8 years of follow-up. Int J Oral Maxillofac Surg. 2024 Oct;53(10):845-852. doi: 10.1016/j.ijom.2024.05.002. Epub 2024 May 27.
Related Links
Access external resources that provide additional context or updates about the study.
This website will allow the calculation of the IDRA of each patient
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
FMDA5/21
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.